Red Blood Cells News and Research

RSS

New treatment option gives hope to victims of head and neck cancers

More than 640,000 people worldwide are diagnosed with head and neck cancer each year, and more than 350,000 die from the disease annually.

19 Oct 2006

FDA approves Taxotere for head and neck cancers

The Food and Drug Administration (FDA) today approved Taxotere (docetaxel) Injection Concentrate for use in combination with cisplatin and fluorouracil prior to radiotherapy for the treatment of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).

18 Oct 2006

New technique allows partial-match cell transplants for children with most resistant leukemia

Clinicians at St. Jude Children's Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.

16 Oct 2006

New technique detects signature of metastasizing melanoma with as few as 10 cancer cells present in blood sample

Researchers at the University of Missouri-Columbia can now detect the spread of skin cancer cells through the blood by literally listening to their sound.

16 Oct 2006

New sunscreen ingredient that actively repairs sunburnt skin

People who suffer from sunburn could soon benefit from a new sunscreen ingredient that actively repairs sunburnt skin and helps prevent the onset of skin cancer, according to research published in the Journal of Investigative Dermatology.

7 Sep 2006

UIC receives $20 million NCI grant to research blood disorders

A $19.6 million National Cancer Institute grant has been awarded to the University of Illinois at Chicago College of Medicine to advance basic and clinical research for incurable blood disorders.

6 Sep 2006

Researchers decode the instructions that tell cells how to become blood

Blood cells have limited lifespans, which means that they must be continually replaced by calling up reserves, and turning these into the blood cell types needed by the body.

4 Sep 2006

Vaccine for severe malaria

The most severe form of malaria hits pregnant women and children the hardest.

1 Sep 2006

Case definitions for human infections with influenza A (H5N1) virus

Prompt and accurate reporting of H5N1 influenza cases to WHO is the cornerstone for monitoring both the global evolution of this disease and the corresponding risk that a pandemic virus might emerge.

30 Aug 2006

Researchers discover one of the malaria parasite's sneakiest tricks

Researchers have discovered one of the malaria parasite's sneakiest tricks--using dead liver cells to cloak and transport itself back into the bloodstream after leaving the liver.

4 Aug 2006

GSK reports significant advance in H5N1 pandemic flu vaccine programme

GlaxoSmithKline (GSK) today announced headline data showing that its H5N1 pandemic flu vaccine achieved a high immune response at a low dose of antigen.

26 Jul 2006

New laser test screens for Hepatitis B

The U.S. Food and Drug Administration has given the go-ahead for a device, called Cell-Dyn Ruby, which uses laser optics and provides diagrams showing changes in white and red blood cells and platelets.

20 Jul 2006

Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease

Researchers have unexpectedly shown that sickle cell-associated kidney injury may be reduced by inhibiting the enzyme activity of a protein that commonly confers protection in other diseased states.

19 Jul 2006

Dog DNA provides clues to combating diseases such as diabetes and multiple sclerosis in humans

Melbourne researchers are examining the DNA of dogs in a research project aiming at determining the genetic causes of common pet diseases - and to provide a model for combating diseases such as diabetes and multiple sclerosis in humans.

5 Jul 2006

FDA grants accelerated approval for Sprycel (dasatinib)

FDA grants accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia (CML),

29 Jun 2006

Affymax and Takeda announce agreement for commercialization of Hematide for anemia

Affymax and Takeda Pharmaceutical Company have announced that the companies have entered into an exclusive global agreement to develop and commercialize Affymax's lead product candidate, Hematide, for the treatment of anemia.

27 Jun 2006

Study holds promise for malarial susceptibility test

Cell and animal studies conducted jointly by scientists at Johns Hopkins, Yale and other institutions have uncovered at least one important contributor to the severe anemia that kills almost half of the 2 million people worldwide who die each year of malaria.

12 May 2006

If jaundice is detected and treated properly children at no greater risk

Newborn babies who are diagnosed with and treated for jaundice are no more likely than other babies to suffer long-term developmental problems, according to a study published in the New England Journal of Medicine.

3 May 2006

DARPA grant supports research toward realizing tissue regeneration

While U.S. soldiers fighting in Iraq and Afghanistan are surviving injuries that in previous conflicts likely would have been fatal, the number of wounded with major tissue loss has never before been so high.

3 May 2006

Simple formula that will enable anesthesiologists to predict blood needs in heart surgery

Duke University Medical Center researchers have developed a simple formula that will enable anesthesiologists to predict, based on individual patient characteristics, how much blood to have on hand in the operating room prior to coronary artery bypass surgery.

3 May 2006